Rare diseases
Investigational molecules
Locations
P Debyelaan 25, 6229 HX Maastricht, The Netherlands
The institution demonstrates significant commitment to advancing understanding and treatment of cardiovascular diseases and associated metabolic conditions. Research efforts concentrate on managing atrial fibrillation through various therapeutic approaches, including investigations into catheter ablation techniques and comparative studies of different ablation strategies. The facility explores innovative interventions for heart failure patients, examining both pharmacological and device-based treatments.
Particular attention is directed toward understanding the interplay between cardiovascular health and metabolic disorders, with studies examining obesity management and its impact on cardiac function. The research portfolio includes investigations into hypertension control and comprehensive approaches to reducing cardiovascular risk through lifestyle and medical interventions.
Academisch Ziekenhuis Maastricht runs clinical trials in conditions such as Non-small cell lung cancer, Lung neoplasm malignant, Small cell lung cancer metastatic, Atrial fibrillation, among others.
Clinical trials run by this sponsor – those enrolling participants first.
The NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe Netherlands
GermanyThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
